留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

应中央军委要求,2022年9月起,《药学实践杂志》将更名为《药学实践与服务》,双月刊,正文96页;2023年1月起,拟出版月刊,正文64页,数据库收录情况与原《药学实践杂志》相同。欢迎作者踊跃投稿!

药师在药物基因组学临床实践中的角色

傅翔 李向荣

傅翔, 李向荣. 药师在药物基因组学临床实践中的角色[J]. 药学实践与服务, 2017, 35(6): 569-572. doi: 10.3969/j.issn.1006-0111.2017.06.022
引用本文: 傅翔, 李向荣. 药师在药物基因组学临床实践中的角色[J]. 药学实践与服务, 2017, 35(6): 569-572. doi: 10.3969/j.issn.1006-0111.2017.06.022
FU Xiang, LI Xiangrong. The role of pharmacist in clinical pharmacogenomics[J]. Journal of Pharmaceutical Practice and Service, 2017, 35(6): 569-572. doi: 10.3969/j.issn.1006-0111.2017.06.022
Citation: FU Xiang, LI Xiangrong. The role of pharmacist in clinical pharmacogenomics[J]. Journal of Pharmaceutical Practice and Service, 2017, 35(6): 569-572. doi: 10.3969/j.issn.1006-0111.2017.06.022

药师在药物基因组学临床实践中的角色

doi: 10.3969/j.issn.1006-0111.2017.06.022

The role of pharmacist in clinical pharmacogenomics

  • 摘要: 药物基因组学的临床实践推动着精准医学的发展。笔者从一名药师的角度,分析药师在药物基因组学临床应用中的主导作用和具体职责,并从国外现阶段的应用实例中探讨药师所面临的挑战和相应对策,为药师今后开展相关服务和实践提供参考。
  • [1] Archibald EG. Inborn Errors of Metabolism[M]. London:Oxford Univercity Press,2013:17.
    [2] Roden DM, Wilke RA, Kroemer HK, et al. Pharmacogenomics:the genetics of variable drug responses[J]. Circulation, 2011,123(15):1661-1670.
    [3] Feero WG, Guttmacher AE, Collins FS. Genomic medicine-an updated primer[J]. N Engl J Med,2010,362(21):2001-2011.
    [4] Beier MT, Panchapagesan M, Carman LE. Pharmacogenetics:has the time come for pharmacists to embrace and implement the science[J]. Consult Pharm,2013,28(11):696-711.
    [5] U.S. National Library of medicine. Genetics home reference:the library[EB/OL].[2014-02-25]. http://ghr.nlm.nih.gov/glossary=personalizedmedicine.
    [6] Swen JJ, Nijenhuis M, de Boer A, et al. Pharmacogenetics:from bench to byte-an update of guidelines[J].Clin Pharmacol Ther,2011,89(5):662-673.
    [7] O'Connor SK, Ferreri SP, Michaels NM,et al.Exploratory planning and implementation of a pilot pharmacogenetic program in a community pharmacy[J]. Pharmacogenomics, 2012,13(8):955-962.
    [8] ASHP statement on the pharmacist's role in clinical pharmacogenomics[J]. Am J Health Syst Pharm, 2015,72(7):579-581.
    [9] Genetics/genomics competency map for pharmacists[EB/OL].[2015-08-20].http://g-2-c-2.org/competency/pharmacist.
    [10] Ferro WG, Kuo GM, Jenkins JF, et al. Pharmacist education in the era of genomic medicine[J]. J Am Pharm Assoc(2003),2012,52(5):e113-e121.
    [11] Hicks JK, Crews KR, Hoffman JM, et al. A cliniciandriven automated system for integration of pharmacogenetic interpretations into an electronic medical record[J]. Clin Pharmacol Ther,2012,92(5):563-566.
    [12] Budnitz DS, Lovegrove MC, Shehab N, et al. Emergency hospitalizations for adverse drug events in older Americans[J]. N Engl J Med,2011,365(21):2002-2012.
    [13] American society of health-system pharmacists. ASHP policy positions 1982-2013[EB/OL].http://www.ashp.org/DocLibrary/BestPractices/policypositionsonly2013.aspx.
    [14] Crews KR, Cross SJ, McCormick JN, et al. Development and implementation of a pharmacist-managed clinical pharmacogenetics service[J]. Am J Health Syst Pharm, 2011,68(2):143-150.
    [15] Charland SL, Agatep BC, Herrera V, et al. Providing patients with pharmacogenetic test results affects adherence to statin therapy:results of the additional KIF6 risk offers better adherence to statins (AKROBATS) trial[J]. Pharmacogenomics J, 2014,14(3):272-280.
    [16] Kisor DF, Bright DR, Conaway M, et al. Pharmacogenetics in the community pharmacy:thienopyridine selection post-coronary artery stent placement[J]. J Pharm Pract, 2014,27(4):416-419.
    [17] Pharmacists' role in pharmacogenomics increasing in an age of precision medicine[EB/OL].[2016-08-03].http://www.pharmacytoday.org/article/S1042-0991(16)30528-X/fulltext.
    [18] Shin J, Kayser SR, Langaee TY. Pharmacogenetics:from discovery to patient care[J]. Am J Health Syst Pharm, 2009,66(7):625-637.
    [19] Relling MV, Klein TE. CPIC:clinical pharmacogenetics implementation consortium of the pharmacogenomics research network[J]. Clin Pharmacol Ther,2011,89(3):464-467.
    [20] Pharmacogenomics knowledge base. Drug labels[EB/OL].http://www.pharmgkb.org/view/drug-labels.do
    [21] Table of pharmacogenomic biomarkers in druglabeling[EB/OL].http://www.fda.gov/drugs/scienceresearch/researchareas/pharmacogenetics/ucm083378.htm
    [22] 徐婵娟,徐玉萍,王春松,等.临床药师参与1例华法林个体化抗凝中基因型检测的临床实践[J].中国医院用药评价与分析,2015,15(9):1256-1258.
    [23] 刘洪涛,连玉菲,庞国勋,等.临床药师参与1例老年心血管病患者的个体化抗血小板治疗实践[J].药学与临床研究,2016,24(2):170-171.
    [24] 魏安华,顾智淳,李娟,等.3例氯吡格雷抵抗患者的药学监护[J].医药导报,2015, 34(12):1668-1670.
  • [1] 孙丹倪, 黄勇, 张嘉宝, 王培.  代谢相关脂肪性肝病的无创诊断与药物治疗的新观点和未来展望 . 药学实践与服务, 2024, 42(10): 411-418. doi: 10.12206/j.issn.2097-2024.202403049
    [2] 夏哲炜, 曾垣烨, 朱海菲, 李育, 陈啸飞.  核磁共振磷谱法测定磷酸氢钙咀嚼片中药物含量 . 药学实践与服务, 2024, 42(9): 399-401, 406. doi: 10.12206/j.issn.2097-2024.202404063
    [3] 杨嘉宁, 赵一颖, 肖伟.  七味脂肝方对非酒精性脂肪性肝炎动物模型的药效学评价 . 药学实践与服务, 2024, 42(9): 389-398. doi: 10.12206/j.issn.2097-2024.202404096
    [4] 陈怡君, 王卓, 何苗, 张宇, 田泾.  泌尿系统碎石术抗菌药物预防使用合理管控实践 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202402034
    [5] 崔亚玲, 吴琼, 马良煜, 胡北, 姚东, 许子华.  肝素钠肌醇烟酸酯乳膏中肌醇烟酸酯皮肤药动学研究 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202404006
    [6] 黄韵, 张正银, 金英, 郑怡菁, 李铁军, 孙莉莉.  耐碳青霉烯类肺炎克雷伯菌及大肠埃希菌临床分离株耐药性及耐药基因分析 . 药学实践与服务, 2024, 42(10): 445-450. doi: 10.12206/j.issn.2097-2024.202309059
    [7] 张元林, 宋凯, 孙蕊, 舒飞, 舒丽芯, 杨樟卫.  基于真实世界数据的药物利用研究综述 . 药学实践与服务, 2024, 42(6): 238-243. doi: 10.12206/j.issn.2097-2024.202312010
    [8] 王雪莲, 郑斯莉, 李志勇, 罗亨宇, 缪朝玉.  全身过表达人METRNL基因小鼠模型的构建与验证 . 药学实践与服务, 2024, 42(5): 198-202, 222. doi: 10.12206/j.issn.2097-2024.202311014
    [9] 宋雨桐, 夏德润, 顾珩, 唐少文, 易洪刚, 沃红梅.  帕博利珠单抗与铂类化疗方案在晚期非小细胞肺癌一线治疗中的药物经济学评价 . 药学实践与服务, 2024, 42(8): 334-340. doi: 10.12206/j.issn.2097-2024.202303023
    [10] 张艺昕, 关欣怡, 王博宁, 闻俊, 洪战英.  二氢吡啶类钙离子拮抗药物手性分析及其立体选择性药动学研究进展 . 药学实践与服务, 2024, 42(8): 319-324. doi: 10.12206/j.issn.2097-2024.202308062
    [11] 崔晓林, 付晓菲, 杜艳红, 刘娟, 朱茜, 刘子祺.  临床药师参与吉瑞替尼致QTc间期延长的病例分析 . 药学实践与服务, 2024, 42(6): 263-266. doi: 10.12206/j.issn.2097-2024.202309050
  • 加载中
计量
  • 文章访问数:  2673
  • HTML全文浏览量:  321
  • PDF下载量:  992
  • 被引次数: 0
出版历程
  • 收稿日期:  2017-05-10
  • 修回日期:  2017-06-19

药师在药物基因组学临床实践中的角色

doi: 10.3969/j.issn.1006-0111.2017.06.022

摘要: 药物基因组学的临床实践推动着精准医学的发展。笔者从一名药师的角度,分析药师在药物基因组学临床应用中的主导作用和具体职责,并从国外现阶段的应用实例中探讨药师所面临的挑战和相应对策,为药师今后开展相关服务和实践提供参考。

English Abstract

傅翔, 李向荣. 药师在药物基因组学临床实践中的角色[J]. 药学实践与服务, 2017, 35(6): 569-572. doi: 10.3969/j.issn.1006-0111.2017.06.022
引用本文: 傅翔, 李向荣. 药师在药物基因组学临床实践中的角色[J]. 药学实践与服务, 2017, 35(6): 569-572. doi: 10.3969/j.issn.1006-0111.2017.06.022
FU Xiang, LI Xiangrong. The role of pharmacist in clinical pharmacogenomics[J]. Journal of Pharmaceutical Practice and Service, 2017, 35(6): 569-572. doi: 10.3969/j.issn.1006-0111.2017.06.022
Citation: FU Xiang, LI Xiangrong. The role of pharmacist in clinical pharmacogenomics[J]. Journal of Pharmaceutical Practice and Service, 2017, 35(6): 569-572. doi: 10.3969/j.issn.1006-0111.2017.06.022
参考文献 (24)

目录

    /

    返回文章
    返回